An anti‐DM regimen consisting of multiple oral agents is a safe and effective alternative to insulin plus OAD and can lead to a comparable reduction in hbA1c at 1‐year in patients who are not willing to use insulin early after diagnosis of T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.